Orbital Metastases of Neuroendocrine Tumors Treated With 177Lu-DOTATATE PRRT or 131I-MIBG Therapies.

Makis, William; McCann, Karey; McEwan, Alexander J B

Makis, William; McCann, Karey; McEwan, Alexander J B.

Affiliation

Makis W; From the Department of Diagnostic Imaging, Cross Cancer Institute, Edmonton, Alberta, Canada.

Clin Nucl Med ; 41(2): 137-41, 2016 Feb.

Article in En | MEDLINE | ID: mdl-26447382

Subject(s)

3-Iodobenzylguanidine/therapeutic use; Neuroendocrine Tumors/radiotherapy; Octreotide/analogs & derivatives; Orbital Neoplasms/radiotherapy; Organometallic Compounds/therapeutic use; Radiopharmaceuticals/therapeutic use; Humans; Neuroendocrine Tumors/pathology; Octreotide/therapeutic use; Orbital Neoplasms/secondary

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Orbital Neoplasms / Octreotide / Neuroendocrine Tumors / Radiopharmaceuticals / 3-Iodobenzylguanidine Limits: Humans Language: En Journal: Clin Nucl Med Year: 2016 Document type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google